AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Allergy Therapeutics plc
Video analysis: AGYTF
All videosNo video analysis for this stock yet. Request one from our team.
News: AGYTF
Boston Scientific beats second quarter expectations, raises full-year outlook
Boston Scientific Corp (NYSE:BSX, XETRA:BSX) reported second quarter results that exceeded analyst expectations for revenue and adjusted earnings, while...
Allergy Therapeutics reports accelerated revenue growth in its second half
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) told investors that revenue growth accelerated in its second half and has guided for a further...
Allergy Therapeutics reports accelerated revenue growth in its second half
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) told investors that revenue growth accelerated in its second half and has guided for a further step-up in the current year as Grassmuno enters its first full peak treatment season. Second-half revenue is expected to reach £23.6 million, up more than 12% on a reported basis from £21 million a year earlier.
Allergy Therapeutics names Helge Weiner-Trapness as executive chair
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) has appointed former HSBC banker Helge Weiner-Trapness as executive chairman as the biotechnology...
Allergy Therapeutics names Helge Weiner-Trapness as executive chair
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) has appointed former HSBC banker Helge Weiner-Trapness as executive chairman as the biotechnology group explores a potential dual primary listing in Hong Kong. Weiner-Trapness, who joined the group as chief strategy officer and an executive director in January 2026, brings more than 30 years of investment banking experience in the US and Asia.